CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project develops a detailed model of how Mycobacterium tuberculosis becomes resistant to the antibiotic isoniazid. By studying over 100 resistant strains, researchers aim to identify molecular mechanisms of resistance and propose effective treatment strategies to combat tuberculosis and other antimicrobial-resista…
Multidrug resistance of Mycobacterium tuberculosis is declared a serious global threat by the World Health Organization.Our project aims at developing a comprehensive model of molecular mechanisms responsible for antimicrobial drug resistance of tuberculosis.
Isoniazid is the main drug used for TB treatment, because it interacts with the bacterial catalasethat leads to the bacterial death.
The library of isoniazid resistant strains (over 100 different strains) will be used asexperimental basis f…
ASTON UNIVERSITY
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
IBC NASU PALLADIN INSTITUTE OF BIOCHEMISTRY OF THE NATIONAL ACADEMY OF
Ukraine, Kyiv
Type: Research institute
Activity type: Research Organisations
SME: No
Ukraine, Kyiv
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
United Kingdom, Guildford
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
